Skip to main content
Premium Trial:

Request an Annual Quote

Nonagen Bioscience: Wayne Hogrefe

Cancer diagnostics firm Nonagen Bioscience has appointed Wayne Hogrefe as COO, where he will oversee the launch of the company's Oncuria bladder cancer assay as a laboratory developed test. He is also a member of the firm's board of directors. Hogrefe was previously senior director of business development and VP of vaccines at clinical trial lab services organization Q2 Solutions and VP of clinical trials at DiaSorin subsidiary Focus Diagnostics.